Hemithoracic Arc Radiotherapy Post Pleural Decortication

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCairo University

About this trial

Malignant Pleural Mesothelioma is an aggressive and refractory disease , the most aggressive treatment plan offered to these patients include trimodalitiy approach with chemotherapy as the mainstay of treatment . the rationale of post operative Radiotherapy is to sterilize the post operative volume to reduce local failure meanwhile minimizing toxicities in this trial we are going to assess the safety and efficacy of Radiotherapy in Mesothelioma patients poat Pleural decortication

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Evidence of metastatic disease.

Underwent Pleural decortication.

Able to provide informed consent.

Disqualifiers

Poor pulmonary function tests.

Recurrent or palliative cases.

Inability to attend full course of Radiotherapy or follow up visits.

Trial design

Design model

Single group

Treatments tested in this trial

  • hemithoracic Volumetric Arc Radiotherapy post Pleural decortication

    Radiation

    post operative delivery of hemithoracic Volumetric Arc Radiotherapy

Treatment groups

45 Participants
are divided into 1 treatment group
Group A: single arm receiving postoperative radiotherapyExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Acute Radiation Toxicity

Questionnaire based Follow up about acute Radiation toxicity according to RTOG including dysnea , cough , chest pain , dysnea on effort from grade 1-5

Time frame
weekly assessment during radiation course and monthly follow up for the first 6 months
2

late radiation toxicity

follow up of patients using both Questionnaire and performing pulmonary function tests and Echo , focusing on DLCO \& FEV1

Time frame
Bi-monthly fashion of minimum 6 months post radiation course

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.